Home / Resource Library / Studies Must Refine Genomic Classification Tools to Improve Use of Targeted Therapies in DLBCL Subgroups

Studies Must Refine Genomic Classification Tools to Improve Use of Targeted Therapies in DLBCL Subgroups

Article reviews biomarkers for diffuse large b-cell lymphoma.